Post-IPO Equity - Evelo Biosciences
Investment Firm
Overview
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Announced Date
Jul 10, 2023
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Evelo Biosciences raised $25500000 on 2023-07-10 in Post-IPO Equity
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 10, 2023 |  Post-IPO Equity - Evelo Biosciences | - | 25.5M | |
| Jul 25, 2019 | Post-IPO Debt - Evelo Biosciences | 1 | - | 45.0M |
| Jul 11, 2017 | Series B - Evelo Biosciences | 5 | - | 50.0M |
| Nov 04, 2015 | Series A - Evelo Biosciences | 1 | - | 35.0M |
Recent Activity
There is no recent news or activity for this profile.